EuroPCR 2013: Innovators are solving TAVI problems ahead of imitators
PARIS — Next year sessions on new devices for transcatheter aortic valve implantation (TAVI) need to move to the main auditorium to accommodate the crowds.There were as many interventional cardiologists standing outside the room as there were sitting inside.
The discussions among presenters and panelists provided insights into the state-of-the-art of this relatively new procedure as important as the clinical findings on the new devices.
To sleep, perchance to analyze data?
OK, I admit it, I love to sleep! If I need any more reminders that I am getting old – thinning hairline, constant aches and pains, the imminent arrival of reading glasses – the fact that I really enjoy going to bed early should be a sign. To me, nothing is more relaxing than a good book and some peace and quiet before nodding off; 10:00 is usually about right. Accompanying me on the bedside table is a sound machine which creates soothing background noise to help drown out the outside world (which is usually the TV in the other room by my night-owl wife). (MDD Perspectives)
Spotlight on Asia: New price cuts unveiled on drug eluting stents in India
Two devices regulated as drugs in India are cardiac stents and drug eluting stents (DES). For years, the market has been dominated by international device manufacturers like Abbott (Abbott Park, Illinois), Boston Scientific (Natick, Massachusetts) and Medtronic (Minneapolis). These companies produce most of the 3 million stents used in India every year.
